Novartis Investigative Site

Los Gatos, California 95032

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Diabetes Mellitus, Type 2

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients — Stopped early